Award
National Institute of Allergy and Infectious Diseases 5R21AI183113-02
Izumo1 in remission in SLE
Recipient
Johns Hopkins University
Award Amount
$198,547.00
Ceiling
$198,547.00
Awarded
December 17, 2024
Identifier
5R21AI183113-02
NIH-funded research project at Johns Hopkins University studying Izumo1's role as a biomarker and therapeutic target in remission of Systemic Lupus Erythematosus (SLE).
Description
This project investigates the role of Izumo1 in remission in Systemic Lupus Erythematosus (SLE). It hypothesizes that soluble levels of Izumo1 increase as a mechanism to activate regulatory pathways that reduce inflammation, potentially serving as a biomarker and therapeutic target for remission in SLE.